Browse 7 Biopharma companies funded by Hillhouse Investment. See funding amounts, founder contacts, and investment details.
Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.
Designing innovative technologies focused on accelerating global access to biotherapeutics.
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Kelun Biotech is a biopharmaceutical company that focuses on the research and development, production and sales of innovative drugs.
Proton Bio is mainly engaged in gene and cell therapy CDMO service provider, focusing on the field of gene and cell therapy.
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds.
HuidaGene is a global clinical-stage biotechnology company pioneering innovative gene therapies for neurology and ophthalmology.
View all companies funded by Hillhouse Investment across every industry and funding stage.
View Full Hillhouse Investment Portfolio